# Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers

> **NCT00548678** · PHASE1 · COMPLETED · sponsor: **Javelin Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** intravenous diclofenac sodium (DIC075V)
- **DRUG:** ketorolac
- **DRUG:** oral diclofenac (Cataflam)
- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT00548678
- **Lead sponsor:** Javelin Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2008-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548678, "Platelet Function and Safety After IV and Oral Diclofenac, IV Ketorolac and Oral Aspirin in Adult Volunteers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00548678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*